Senate Considers Revoking Pharmacist "Conscience Clauses"
A pharmacist's right to refuse to dispenseprescription contraceptives orother drugs on moral or religiousgrounds would be revoked under newlegislation now being debated on CapitolHill. The bill, introduced by Sen.Barbara Boxer (D, CA), would requirepharmacies to "fill all valid prescriptionswithout unnecessary delay orinterference."
According to Boxer, the legislationis a response to growing complaintsfrom women "about pharmacists refusingto fill prescriptions for contraceptivesbecause of their personal beliefs,not their medical concerns." Arguingthat "access to pharmaceuticals shoulddepend on medical judgments, notpersonal ideology," she warned Congressthat, unless action is taken toaddress this problem now, "tomorrowpharmacists could refuse to dispenseany drug for any medical condition."
Under the proposal, all pharmaciesthat accept reimbursement from Medicaidor the new Medicare Part D drugprogram would be federally obliged tofill any valid prescription-notwithstandingreligious considerations orstate "conscience clause" laws protectingpharmacists from being forced todispense drugs that create moral problemsfor them.
"That means, if the item is not instock, the pharmacy should order itaccording to its standard procedures,or, if the customer prefers, transfer it toanother pharmacy or give the prescriptionback," Boxer explained. In seekingSenate support for the bill, the CaliforniaDemocrat stressed that her proposalwould not interfere with valid "medicalreasons" for declining to honor aprescription, "including problems withdosages, harmful interactions withother drugs, or potential drug abuse."
Boxer also attempted to defuseobjections that the measure wouldoverride the religious beliefs of pharmacists."In this bill, it is the responsibilityof the pharmacy, not the pharmacist,to ensure that prescriptions arefilled," she said. "Pharmacies canaccommodate their employees in anymanner that they wish, as long as customersget their medications withoutdelay, interference, or harassment."
Mr. Rankin is a freelance medical writer.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
Evaluation of Pharmacist-Driven Penicillin Allergy ReconciliationSeptember 17th 2025
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActSeptember 16th 2025
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy ResearchSeptember 15th 2025
